The 21- and 23-kD forms of TCRζ are generated by specific ITAM phosphorylations
- Nicolai S.C. Van Oers(corresponding author),
- Brett Tohlen,
- Bernard Malissen,
- Carolyn R. Moomaw,
- Steve Afendis,
- University of Texas Southwestern Medical Center,
- Institut national de la santé et de la recherche médicale
Scholary Output:
Contribution to journal
Article
Peer-reviewAbstract
The T cell receptor (TCR) ζ subunit contains three immunoreceptor tyrosine-based activation motifs (ITAMs) that translate effective extracellular ligand binding into intracellular signals by becoming phosphorylated into 21- and 23-kD forms. We report here that the 21-kD form of TCRζ is generated by phosphorylation of the tyrosines in the second and third ITAMs, whereas the 23-kD form is formed by the additional phosphorylation of the membrane-proximal ITAM tyrosines. The stable formation of the 21- and 23-kD species requires the binding of the tandem SH2 domains of ZAP-70. We also report that TCR-mediated signaling processes can proceed independently of either the 21- or 23-kD species of TCRζ.
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 322-328 (7 pages)Journal (Volume, Issue Number)
Nature Immunology (Volume 1, Issue 4)Publication milestones
- Published - 10/2000
Publication status
Published - 10/2000
ISSN
1529-2908Publication IDs
- Scopus: 0034305516
- PubMed: 11017104
Publication metrics
Metrics
SciVal
FWCI
1.64
SciVal
Author count
6
SciVal
citations
78
SciVal
Paper percentile
90
SciVal
Top percentile
10
Fractional count
1
Fractional count
0.17
Fractional count
5
Fractional count
0.83
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Captures
35
Citation count
84
Funding Details
Acknowledgments We thank J. Ritter for generation of mice; ˙H. Nikaidoh and staff from the Children’s Medical Center of Dallas;A.Weiss, D. Kioussis and M. Cobb for discussions; D. Kioussis for VA-CD2 transgenic constructs.This work was supported in part by a grant from the NIH (RO1 AI42953 to N. S. C.V. O.) and the Howard Hughes Medical Institute (C.A. S).
